Clostridium Perfringens Septicemia: A Critical Emergency Department Identification

Intravascular hemolysis in the presence of infection should prompt emergency physicians (EPs) to consider Clostridium perfringens septicemia and to act quickly to treat the infection. C perfringens septicemia is a rare, rapidly fatal disease with a reported mortality rate of at least 70%.¹ Its expeditious lethality is due to a combination 7-minute doubling time of the organism and its production of a multitude of virulent toxins.¹

This disease is deceptive: Patients may not appear to be severely ill and may be hemodynamically stable, not meeting systemic inflammatory response syndrome (SIRS) criteria, yet they rapidly decompensate. No interventions have been shown to reliably change outcome; however, the best hope for survival lays in early identification and definitive treatment with intravenous (IV) antibiotics and surgical intervention for source control. The authors present a fatal ED case of massive acute intravascular hemolysis due to C perfringens septicemia, the result of a cryptic liver abscess.

Case

A 74-year-old man with noninsulin-dependent diabetes mellitus (DM) and hypertension was transferred from an outside hospital to a tertiary-care referral center for leukocytosis and hyperbilirubinemia, where he had presented with fatigue and jaundice. A year prior, he had a cholecystectomy complicated by accidental hepatic artery ligation necessitating biliary tract reconstruction, but had been well since that event.

At the outside hospital, blood tests revealed a white blood cell (WBC) count of 21.0 x 10⁹/L and elevated values on liver function tests with an elevated indirect hyperbilirubinemia. A right upper quadrant ultrasound showed a poorly defined hyperechoic mass behind the liver, but no bile-duct dilation or stones.

On arrival, the patient’s vital signs were: temperature, 100.4°F; heart rate, 92 beats/minute; blood pressure, 187/98 mm Hg; respiratory rate, 18 breaths/minute. His oxygen saturation was 97% on room air. An electrocardiogram showed sinus rhythm with a nonspecific intraventricular conduction delay with strain pattern. He was awake, comfortable, and conversant and oriented to place and person, but not to time. He was markedly jaundiced with scleral icterus, dry mucosal membranes, and foul breath. His neck was supple and nontender. His heart had a regular rate and rhythm, without murmur, rubs, or gallops, and his lungs were bilaterally clear to auscultation. The patient’s obese abdomen was soft and nontender, without rebound or guarding. He moved in a coordinated manner, and had no clonus or asterixis.

Repeat laboratory evaluation revealed a WBC of 32.2 x10⁹/L, an elevated troponin level of 0.30 ng/mL, and an increased brain natriuretic peptide (BNP) of 636.2 pg/mL. Prothrombin time (PT) and international normalized ratio (INR) were normal. The chemistry test was reported as hemolyzed. Blood samples were redrawn three additional times, but each time the laboratory reported that each sample appeared progressively more hemolyzed and they were unable to obtain testable serum (Figure 1).

During his ED workup, the patient became more pale and jaundiced and began to produce bright red urine. The authors suspected that his hemolyzed blood samples were not due to blood draw artifact, but to intravascular hemolysis. A review of the blood smear showed gram-positive positive bacilli and ghost cells, commonly observed in hemolysis. Repeat laboratory tests showed interval increases in partial thromboplastin time, PT, and INR, and a D-dimer value of 3,621 ng/mL. Fibrinogen could not be measured due to gross hemolysis.

Empiric IV vancomycin and piperacillin/tazobactam were administered, and computed tomography (CT) studies of the brain and abdomen were ordered. The CT of the brain was normal; however, CT of the abdomen revealed an air-filled abscess in the right hepatic lobe and air in the left hepatic lobe and biliary tree without biliary dilation or wall thickening (Figure 2).

After discussion with cardiology, the medical intensive care team, and general surgery services, the patient was admitted to the surgical intensive care unit (SICU) with a plan to percutaneously drain the abscess the next morning.  

Six and a half hours after arriving at the ED, the patient became acutely confused, tachypneic (RR, 22 breaths/minute) and tachycardic (HR, 102 beats/minute). On arrival to the SICU, he became unresponsive and pulseless. Resuscitation attempts were unsuccessful and the patient died.

Discussion

C perfringens is an anaerobic gram-positive bacillus known for causing gas gangrene and is normally found in the human gastrointestinal (GI) and genital tracts. Individuals most at risk for C perfringens septicemia have underlying hepatobiliary or genitourinary tract disease, malignancy, immunosuppression, DM, or recent history of GI or genitourinary surgery.^2,3

Hemolysis has been observed in 7% to 15% of C perfringens bacteremias.³ This is caused by C perfringens’ primary toxin, phospholipase C lecithinase (α-toxin), which splits lecithin in the red blood-cell membrane thereby damaging its structural integrity and causing hemolysis.⁴ Other virulent factors of C perfringens are β-, ε-, and τ- toxins, all of which cause capillary leakage by damaging the vascular endothelium.⁵

Hemolysis with signs of septic shock due to C perfringens infection has been almost invariably fatal in several small case series reviews.^2,3 While definitive identification of C perfringens is often delayed, it may be identified on gram stain; a DNA polymerase chain reaction (PCR) test has been developed, but is not widely available.⁶

The deceptive severity of this patient’s illness is a hallmark of C perfringens sepsis. Many patients may appear calm and report they feel “fine.” This lack of concern, “la belle indifférence,” is also seen in patients with necrotizing soft-tissue infections.⁷

Patients may be hemodynamically normal or fail to meet SIRS criteria. Case series have revealed no difference in SIRS criteria between survivors and nonsurvivors of C perfringens septicemia²; however, survivors were observed to have higher plasma fibrinogen levels than nonsurvivors.² Fibrinogen, which is a known risk factor for the development of shock,⁸ may be a useful prognostic indicator given the association between shock and death in C perfringens septicemia.²

These factors were evident in this case. During the first 5 hours in the ED, the patient was hemodynamically normal, meeting only one of the SIRS criteria (elevated WBC). He also exhibited a nonchalant attitude, saying he “felt fine” before his rapid decline and death. Although fibrinogen was not available, this case is a clear reminder that exclusive use of SIRS criteria and patient reporting as barometers for severity of illness can be misleading.

Treatment

First-line treatment for C Perfringens includes high-dose IV penicillin G (10-24 million units daily), clindamycin for suppression of toxin synthesis, and surgical debridement.^1,10 Second-line antibiotics include penicillin derivatives, chloramphenicol, doxycycline, carbapenems, tetracycline, and metronidazole.^10,11

Immediate surgical intervention may be needed for survival. Limited review studies from Tokyo and the Netherlands indicate that surgical intervention is a strong prognostic indicator of survival and should be pursued expediently.^2,3 A Dutch review ³ of 40 cases in the English medical literature published since 1990 demonstrated an overall mortality rate of 80% (32 of 40 patients). Among eight patients who had a surgical intervention (eg, hysterectomy, drainage of liver abscess) two deaths (25%) occurred. Those patients medically managed had a mortality rate of 93.7% (30/32 patients). While there is an impressive difference between these two groups—the authors assert a relative risk of mortality with surgical intervention of 0.27 (95% CI 0.08 to 0.89)—they are incomparable as many individuals in the medically managed group were not candidates for surgical intervention due to multiorgan failure or death prior to diagnosis.

While the strength of evidence for the efficacy of other interventions is limited, observational data suggest novel interventions are worth considering in an attempt to save these patients. Hyperbaric oxygen therapy has been used with some success in combination with surgery for gas gangrene and necrotizing soft-tissue infections; a few observational studies have shown benefit in sepsis.¹¹ In the setting of massive hemolysis, blood transfusion may be required.¹² If hemolysis is caught in early stages, exchange transfusion may prevent further complications.¹³ The α-toxin antitoxin, historically used for gas gangrene, has been abandoned in the United States due to severe allergic reactions and poor efficacy.¹⁴ However, researchers in Japan are investigating the efficacy of antitoxin for C perfringens liver abscesses when multiorgan failure prohibits surgical intervention.¹⁵

Conclusion

C perfringens septicemia should be considered when intravascular hemolysis is encountered, even in patients not meeting SIRS criteria. Treatment with appropriate antibiotics and an expedited search for a source (with subsequent immediate intervention) must be initiated prior to onset of shock if there is any hope of survival. If C perfringens septicemia is suspected, clear communication with family members and consultants about the seriousness of the patient’s condition is of the upmost importance as all parties involved must be made aware of the aggressive and unrelenting course of this disease and high likelihood of death.

Dr Samuels is a third-year resident in the department of emergency medicine at Brown University, Providence, Rhode Island. Dr Hack is the division director of medical toxicology at the University of Emergency Medicine Foundation; director of the educational program in medical toxicology and an associate professor at Warren Alpert Medical School; and an attending physician in the department of emergency medicine at Brown University, Rhode Island Hospital, Miriam Hospital, Providence.

Intravascular hemolysis in the presence of infection should prompt emergency physicians (EPs) to consider Clostridium perfringens septicemia and to act quickly to treat the infection. C perfringens septicemia is a rare, rapidly fatal disease with a reported mortality rate of at least 70%.¹ Its expeditious lethality is due to a combination 7-minute doubling time of the organism and its production of a multitude of virulent toxins.¹

This disease is deceptive: Patients may not appear to be severely ill and may be hemodynamically stable, not meeting systemic inflammatory response syndrome (SIRS) criteria, yet they rapidly decompensate. No interventions have been shown to reliably change outcome; however, the best hope for survival lays in early identification and definitive treatment with intravenous (IV) antibiotics and surgical intervention for source control. The authors present a fatal ED case of massive acute intravascular hemolysis due to C perfringens septicemia, the result of a cryptic liver abscess.

Case

A 74-year-old man with noninsulin-dependent diabetes mellitus (DM) and hypertension was transferred from an outside hospital to a tertiary-care referral center for leukocytosis and hyperbilirubinemia, where he had presented with fatigue and jaundice. A year prior, he had a cholecystectomy complicated by accidental hepatic artery ligation necessitating biliary tract reconstruction, but had been well since that event.

At the outside hospital, blood tests revealed a white blood cell (WBC) count of 21.0 x 10⁹/L and elevated values on liver function tests with an elevated indirect hyperbilirubinemia. A right upper quadrant ultrasound showed a poorly defined hyperechoic mass behind the liver, but no bile-duct dilation or stones.

On arrival, the patient’s vital signs were: temperature, 100.4°F; heart rate, 92 beats/minute; blood pressure, 187/98 mm Hg; respiratory rate, 18 breaths/minute. His oxygen saturation was 97% on room air. An electrocardiogram showed sinus rhythm with a nonspecific intraventricular conduction delay with strain pattern. He was awake, comfortable, and conversant and oriented to place and person, but not to time. He was markedly jaundiced with scleral icterus, dry mucosal membranes, and foul breath. His neck was supple and nontender. His heart had a regular rate and rhythm, without murmur, rubs, or gallops, and his lungs were bilaterally clear to auscultation. The patient’s obese abdomen was soft and nontender, without rebound or guarding. He moved in a coordinated manner, and had no clonus or asterixis.

Repeat laboratory evaluation revealed a WBC of 32.2 x10⁹/L, an elevated troponin level of 0.30 ng/mL, and an increased brain natriuretic peptide (BNP) of 636.2 pg/mL. Prothrombin time (PT) and international normalized ratio (INR) were normal. The chemistry test was reported as hemolyzed. Blood samples were redrawn three additional times, but each time the laboratory reported that each sample appeared progressively more hemolyzed and they were unable to obtain testable serum (Figure 1).

During his ED workup, the patient became more pale and jaundiced and began to produce bright red urine. The authors suspected that his hemolyzed blood samples were not due to blood draw artifact, but to intravascular hemolysis. A review of the blood smear showed gram-positive positive bacilli and ghost cells, commonly observed in hemolysis. Repeat laboratory tests showed interval increases in partial thromboplastin time, PT, and INR, and a D-dimer value of 3,621 ng/mL. Fibrinogen could not be measured due to gross hemolysis.

Empiric IV vancomycin and piperacillin/tazobactam were administered, and computed tomography (CT) studies of the brain and abdomen were ordered. The CT of the brain was normal; however, CT of the abdomen revealed an air-filled abscess in the right hepatic lobe and air in the left hepatic lobe and biliary tree without biliary dilation or wall thickening (Figure 2).

After discussion with cardiology, the medical intensive care team, and general surgery services, the patient was admitted to the surgical intensive care unit (SICU) with a plan to percutaneously drain the abscess the next morning.  

Six and a half hours after arriving at the ED, the patient became acutely confused, tachypneic (RR, 22 breaths/minute) and tachycardic (HR, 102 beats/minute). On arrival to the SICU, he became unresponsive and pulseless. Resuscitation attempts were unsuccessful and the patient died.

Discussion

C perfringens is an anaerobic gram-positive bacillus known for causing gas gangrene and is normally found in the human gastrointestinal (GI) and genital tracts. Individuals most at risk for C perfringens septicemia have underlying hepatobiliary or genitourinary tract disease, malignancy, immunosuppression, DM, or recent history of GI or genitourinary surgery.^2,3

Hemolysis has been observed in 7% to 15% of C perfringens bacteremias.³ This is caused by C perfringens’ primary toxin, phospholipase C lecithinase (α-toxin), which splits lecithin in the red blood-cell membrane thereby damaging its structural integrity and causing hemolysis.⁴ Other virulent factors of C perfringens are β-, ε-, and τ- toxins, all of which cause capillary leakage by damaging the vascular endothelium.⁵

Hemolysis with signs of septic shock due to C perfringens infection has been almost invariably fatal in several small case series reviews.^2,3 While definitive identification of C perfringens is often delayed, it may be identified on gram stain; a DNA polymerase chain reaction (PCR) test has been developed, but is not widely available.⁶

The deceptive severity of this patient’s illness is a hallmark of C perfringens sepsis. Many patients may appear calm and report they feel “fine.” This lack of concern, “la belle indifférence,” is also seen in patients with necrotizing soft-tissue infections.⁷

Patients may be hemodynamically normal or fail to meet SIRS criteria. Case series have revealed no difference in SIRS criteria between survivors and nonsurvivors of C perfringens septicemia²; however, survivors were observed to have higher plasma fibrinogen levels than nonsurvivors.² Fibrinogen, which is a known risk factor for the development of shock,⁸ may be a useful prognostic indicator given the association between shock and death in C perfringens septicemia.²

These factors were evident in this case. During the first 5 hours in the ED, the patient was hemodynamically normal, meeting only one of the SIRS criteria (elevated WBC). He also exhibited a nonchalant attitude, saying he “felt fine” before his rapid decline and death. Although fibrinogen was not available, this case is a clear reminder that exclusive use of SIRS criteria and patient reporting as barometers for severity of illness can be misleading.

Treatment

First-line treatment for C Perfringens includes high-dose IV penicillin G (10-24 million units daily), clindamycin for suppression of toxin synthesis, and surgical debridement.^1,10 Second-line antibiotics include penicillin derivatives, chloramphenicol, doxycycline, carbapenems, tetracycline, and metronidazole.^10,11

Immediate surgical intervention may be needed for survival. Limited review studies from Tokyo and the Netherlands indicate that surgical intervention is a strong prognostic indicator of survival and should be pursued expediently.^2,3 A Dutch review ³ of 40 cases in the English medical literature published since 1990 demonstrated an overall mortality rate of 80% (32 of 40 patients). Among eight patients who had a surgical intervention (eg, hysterectomy, drainage of liver abscess) two deaths (25%) occurred. Those patients medically managed had a mortality rate of 93.7% (30/32 patients). While there is an impressive difference between these two groups—the authors assert a relative risk of mortality with surgical intervention of 0.27 (95% CI 0.08 to 0.89)—they are incomparable as many individuals in the medically managed group were not candidates for surgical intervention due to multiorgan failure or death prior to diagnosis.

While the strength of evidence for the efficacy of other interventions is limited, observational data suggest novel interventions are worth considering in an attempt to save these patients. Hyperbaric oxygen therapy has been used with some success in combination with surgery for gas gangrene and necrotizing soft-tissue infections; a few observational studies have shown benefit in sepsis.¹¹ In the setting of massive hemolysis, blood transfusion may be required.¹² If hemolysis is caught in early stages, exchange transfusion may prevent further complications.¹³ The α-toxin antitoxin, historically used for gas gangrene, has been abandoned in the United States due to severe allergic reactions and poor efficacy.¹⁴ However, researchers in Japan are investigating the efficacy of antitoxin for C perfringens liver abscesses when multiorgan failure prohibits surgical intervention.¹⁵

Conclusion

C perfringens septicemia should be considered when intravascular hemolysis is encountered, even in patients not meeting SIRS criteria. Treatment with appropriate antibiotics and an expedited search for a source (with subsequent immediate intervention) must be initiated prior to onset of shock if there is any hope of survival. If C perfringens septicemia is suspected, clear communication with family members and consultants about the seriousness of the patient’s condition is of the upmost importance as all parties involved must be made aware of the aggressive and unrelenting course of this disease and high likelihood of death.

Dr Samuels is a third-year resident in the department of emergency medicine at Brown University, Providence, Rhode Island. Dr Hack is the division director of medical toxicology at the University of Emergency Medicine Foundation; director of the educational program in medical toxicology and an associate professor at Warren Alpert Medical School; and an attending physician in the department of emergency medicine at Brown University, Rhode Island Hospital, Miriam Hospital, Providence.

Intravascular hemolysis in the presence of infection should prompt emergency physicians (EPs) to consider Clostridium perfringens septicemia and to act quickly to treat the infection. C perfringens septicemia is a rare, rapidly fatal disease with a reported mortality rate of at least 70%.¹ Its expeditious lethality is due to a combination 7-minute doubling time of the organism and its production of a multitude of virulent toxins.¹

This disease is deceptive: Patients may not appear to be severely ill and may be hemodynamically stable, not meeting systemic inflammatory response syndrome (SIRS) criteria, yet they rapidly decompensate. No interventions have been shown to reliably change outcome; however, the best hope for survival lays in early identification and definitive treatment with intravenous (IV) antibiotics and surgical intervention for source control. The authors present a fatal ED case of massive acute intravascular hemolysis due to C perfringens septicemia, the result of a cryptic liver abscess.

Case

A 74-year-old man with noninsulin-dependent diabetes mellitus (DM) and hypertension was transferred from an outside hospital to a tertiary-care referral center for leukocytosis and hyperbilirubinemia, where he had presented with fatigue and jaundice. A year prior, he had a cholecystectomy complicated by accidental hepatic artery ligation necessitating biliary tract reconstruction, but had been well since that event.

At the outside hospital, blood tests revealed a white blood cell (WBC) count of 21.0 x 10⁹/L and elevated values on liver function tests with an elevated indirect hyperbilirubinemia. A right upper quadrant ultrasound showed a poorly defined hyperechoic mass behind the liver, but no bile-duct dilation or stones.

On arrival, the patient’s vital signs were: temperature, 100.4°F; heart rate, 92 beats/minute; blood pressure, 187/98 mm Hg; respiratory rate, 18 breaths/minute. His oxygen saturation was 97% on room air. An electrocardiogram showed sinus rhythm with a nonspecific intraventricular conduction delay with strain pattern. He was awake, comfortable, and conversant and oriented to place and person, but not to time. He was markedly jaundiced with scleral icterus, dry mucosal membranes, and foul breath. His neck was supple and nontender. His heart had a regular rate and rhythm, without murmur, rubs, or gallops, and his lungs were bilaterally clear to auscultation. The patient’s obese abdomen was soft and nontender, without rebound or guarding. He moved in a coordinated manner, and had no clonus or asterixis.

Repeat laboratory evaluation revealed a WBC of 32.2 x10⁹/L, an elevated troponin level of 0.30 ng/mL, and an increased brain natriuretic peptide (BNP) of 636.2 pg/mL. Prothrombin time (PT) and international normalized ratio (INR) were normal. The chemistry test was reported as hemolyzed. Blood samples were redrawn three additional times, but each time the laboratory reported that each sample appeared progressively more hemolyzed and they were unable to obtain testable serum (Figure 1).

During his ED workup, the patient became more pale and jaundiced and began to produce bright red urine. The authors suspected that his hemolyzed blood samples were not due to blood draw artifact, but to intravascular hemolysis. A review of the blood smear showed gram-positive positive bacilli and ghost cells, commonly observed in hemolysis. Repeat laboratory tests showed interval increases in partial thromboplastin time, PT, and INR, and a D-dimer value of 3,621 ng/mL. Fibrinogen could not be measured due to gross hemolysis.

Empiric IV vancomycin and piperacillin/tazobactam were administered, and computed tomography (CT) studies of the brain and abdomen were ordered. The CT of the brain was normal; however, CT of the abdomen revealed an air-filled abscess in the right hepatic lobe and air in the left hepatic lobe and biliary tree without biliary dilation or wall thickening (Figure 2).

After discussion with cardiology, the medical intensive care team, and general surgery services, the patient was admitted to the surgical intensive care unit (SICU) with a plan to percutaneously drain the abscess the next morning.  

Six and a half hours after arriving at the ED, the patient became acutely confused, tachypneic (RR, 22 breaths/minute) and tachycardic (HR, 102 beats/minute). On arrival to the SICU, he became unresponsive and pulseless. Resuscitation attempts were unsuccessful and the patient died.

Discussion

C perfringens is an anaerobic gram-positive bacillus known for causing gas gangrene and is normally found in the human gastrointestinal (GI) and genital tracts. Individuals most at risk for C perfringens septicemia have underlying hepatobiliary or genitourinary tract disease, malignancy, immunosuppression, DM, or recent history of GI or genitourinary surgery.^2,3

Hemolysis has been observed in 7% to 15% of C perfringens bacteremias.³ This is caused by C perfringens’ primary toxin, phospholipase C lecithinase (α-toxin), which splits lecithin in the red blood-cell membrane thereby damaging its structural integrity and causing hemolysis.⁴ Other virulent factors of C perfringens are β-, ε-, and τ- toxins, all of which cause capillary leakage by damaging the vascular endothelium.⁵

Hemolysis with signs of septic shock due to C perfringens infection has been almost invariably fatal in several small case series reviews.^2,3 While definitive identification of C perfringens is often delayed, it may be identified on gram stain; a DNA polymerase chain reaction (PCR) test has been developed, but is not widely available.⁶

The deceptive severity of this patient’s illness is a hallmark of C perfringens sepsis. Many patients may appear calm and report they feel “fine.” This lack of concern, “la belle indifférence,” is also seen in patients with necrotizing soft-tissue infections.⁷

Patients may be hemodynamically normal or fail to meet SIRS criteria. Case series have revealed no difference in SIRS criteria between survivors and nonsurvivors of C perfringens septicemia²; however, survivors were observed to have higher plasma fibrinogen levels than nonsurvivors.² Fibrinogen, which is a known risk factor for the development of shock,⁸ may be a useful prognostic indicator given the association between shock and death in C perfringens septicemia.²

These factors were evident in this case. During the first 5 hours in the ED, the patient was hemodynamically normal, meeting only one of the SIRS criteria (elevated WBC). He also exhibited a nonchalant attitude, saying he “felt fine” before his rapid decline and death. Although fibrinogen was not available, this case is a clear reminder that exclusive use of SIRS criteria and patient reporting as barometers for severity of illness can be misleading.

Treatment

First-line treatment for C Perfringens includes high-dose IV penicillin G (10-24 million units daily), clindamycin for suppression of toxin synthesis, and surgical debridement.^1,10 Second-line antibiotics include penicillin derivatives, chloramphenicol, doxycycline, carbapenems, tetracycline, and metronidazole.^10,11

Immediate surgical intervention may be needed for survival. Limited review studies from Tokyo and the Netherlands indicate that surgical intervention is a strong prognostic indicator of survival and should be pursued expediently.^2,3 A Dutch review ³ of 40 cases in the English medical literature published since 1990 demonstrated an overall mortality rate of 80% (32 of 40 patients). Among eight patients who had a surgical intervention (eg, hysterectomy, drainage of liver abscess) two deaths (25%) occurred. Those patients medically managed had a mortality rate of 93.7% (30/32 patients). While there is an impressive difference between these two groups—the authors assert a relative risk of mortality with surgical intervention of 0.27 (95% CI 0.08 to 0.89)—they are incomparable as many individuals in the medically managed group were not candidates for surgical intervention due to multiorgan failure or death prior to diagnosis.

While the strength of evidence for the efficacy of other interventions is limited, observational data suggest novel interventions are worth considering in an attempt to save these patients. Hyperbaric oxygen therapy has been used with some success in combination with surgery for gas gangrene and necrotizing soft-tissue infections; a few observational studies have shown benefit in sepsis.¹¹ In the setting of massive hemolysis, blood transfusion may be required.¹² If hemolysis is caught in early stages, exchange transfusion may prevent further complications.¹³ The α-toxin antitoxin, historically used for gas gangrene, has been abandoned in the United States due to severe allergic reactions and poor efficacy.¹⁴ However, researchers in Japan are investigating the efficacy of antitoxin for C perfringens liver abscesses when multiorgan failure prohibits surgical intervention.¹⁵

Conclusion

C perfringens septicemia should be considered when intravascular hemolysis is encountered, even in patients not meeting SIRS criteria. Treatment with appropriate antibiotics and an expedited search for a source (with subsequent immediate intervention) must be initiated prior to onset of shock if there is any hope of survival. If C perfringens septicemia is suspected, clear communication with family members and consultants about the seriousness of the patient’s condition is of the upmost importance as all parties involved must be made aware of the aggressive and unrelenting course of this disease and high likelihood of death.

Dr Samuels is a third-year resident in the department of emergency medicine at Brown University, Providence, Rhode Island. Dr Hack is the division director of medical toxicology at the University of Emergency Medicine Foundation; director of the educational program in medical toxicology and an associate professor at Warren Alpert Medical School; and an attending physician in the department of emergency medicine at Brown University, Rhode Island Hospital, Miriam Hospital, Providence.